Portage Learning; Essential Biology II W/Lab BIOL 102/BIOD 102
Module 5 Exam All Versions Latest Update/ Verified
Institution: Portage Learning
Course Code: BIOL 102/BIOD 102
Course Title: Essential Biology II W/Lab
Exam: Module 5
Assessment Type: Examination
Edition: Updated Version
Student Name: _______________________________
Student Id: _________________________________
Instructor: _________________________________
Instructions:
Answer All Questions.
Choose The Correct Answer
TABLE OF CONTENT
Version Exam Module 5.1 ______________________________________________________ 2
Version Exam Module 5.2 _____________________________________________________ 21
QUESTIONS TYPE:
➢ Multiple Choice:
➢ True Or False:
➢ Explain Or Describe
➢ Fill In The Blank
All The Best!!
,Version Exam Module 5.1
Question 1.
Multiple Choice:
Which Of The Following Is Concerned With The Treatment Of Disease And Suffering?
A. Therapeutics
B. Pharmaceutics
C. Pharmacology
D. Pharmacotherapies
Therapeutics Is The Branch Of Medicine Concerned With The Treatment And Relief Of
Disease And Suffering.
Question 2.
Multiple Choice:
Vaccines, Hormones, And Insulin Are Examples Of:
A. Synthetic Drugs
B. Analgesics
C. Biologics
D. Antibiotics
Biologics Are Medical Products Derived From Living Organisms, Such As Vaccines,
Hormones, And Insulin.
,Question 3.
Multiple Choice:
The Goal Of The Preclinical Phase Is To Determine Which Drugs Are:
A. Not Safe
B. Safe
C. Efficacious
D. Approved
The Preclinical Phase Identifies Drugs That Are Not Safe Before Moving Forward To
Human Trials.
Question 4
Multiple Choice:
The Clinical Investigation Stage Of Drug Development Is Important For Determining
Each Of The Following Except:
A. Adverse Effects
B. Improvement Of Condition
C. Worsening Of Other Conditions
D. Dosage Levels
Clinical Investigation Evaluates Safety (Adverse Effects), Risks (Worsening Conditions),
And Dosage, But Improvement Of Condition Is Not The Exception In This Context
Based On The Provided Answer Key.
, Question 5.
Multiple Choice:
During The NDA Process, If There Is A Concern Regarding Safety Or Effectiveness
Data, What Will Occur?
A. The Process Is Permanently Halted
B. The Process Is Continued
C. Developers Are Given The Opportunity For Remediations
D. The Process Must Begin Again At Pre-Clinical Studies
If Safety Or Effectiveness Concerns Arise, Developers Are Typically Given An
Opportunity To Address And Remediate The Issues.
Question 6.
Multiple Choice:
During The Post-Marketing Phase, Focus Remains On ______ Within The General
Population.
A. Adverse Events
B. Profit Margin
C. Toxicity
D. None Of The Above
The Post-Marketing Phase Monitors Adverse Events To Ensure Continued Safety In The
General Population.
Module 5 Exam All Versions Latest Update/ Verified
Institution: Portage Learning
Course Code: BIOL 102/BIOD 102
Course Title: Essential Biology II W/Lab
Exam: Module 5
Assessment Type: Examination
Edition: Updated Version
Student Name: _______________________________
Student Id: _________________________________
Instructor: _________________________________
Instructions:
Answer All Questions.
Choose The Correct Answer
TABLE OF CONTENT
Version Exam Module 5.1 ______________________________________________________ 2
Version Exam Module 5.2 _____________________________________________________ 21
QUESTIONS TYPE:
➢ Multiple Choice:
➢ True Or False:
➢ Explain Or Describe
➢ Fill In The Blank
All The Best!!
,Version Exam Module 5.1
Question 1.
Multiple Choice:
Which Of The Following Is Concerned With The Treatment Of Disease And Suffering?
A. Therapeutics
B. Pharmaceutics
C. Pharmacology
D. Pharmacotherapies
Therapeutics Is The Branch Of Medicine Concerned With The Treatment And Relief Of
Disease And Suffering.
Question 2.
Multiple Choice:
Vaccines, Hormones, And Insulin Are Examples Of:
A. Synthetic Drugs
B. Analgesics
C. Biologics
D. Antibiotics
Biologics Are Medical Products Derived From Living Organisms, Such As Vaccines,
Hormones, And Insulin.
,Question 3.
Multiple Choice:
The Goal Of The Preclinical Phase Is To Determine Which Drugs Are:
A. Not Safe
B. Safe
C. Efficacious
D. Approved
The Preclinical Phase Identifies Drugs That Are Not Safe Before Moving Forward To
Human Trials.
Question 4
Multiple Choice:
The Clinical Investigation Stage Of Drug Development Is Important For Determining
Each Of The Following Except:
A. Adverse Effects
B. Improvement Of Condition
C. Worsening Of Other Conditions
D. Dosage Levels
Clinical Investigation Evaluates Safety (Adverse Effects), Risks (Worsening Conditions),
And Dosage, But Improvement Of Condition Is Not The Exception In This Context
Based On The Provided Answer Key.
, Question 5.
Multiple Choice:
During The NDA Process, If There Is A Concern Regarding Safety Or Effectiveness
Data, What Will Occur?
A. The Process Is Permanently Halted
B. The Process Is Continued
C. Developers Are Given The Opportunity For Remediations
D. The Process Must Begin Again At Pre-Clinical Studies
If Safety Or Effectiveness Concerns Arise, Developers Are Typically Given An
Opportunity To Address And Remediate The Issues.
Question 6.
Multiple Choice:
During The Post-Marketing Phase, Focus Remains On ______ Within The General
Population.
A. Adverse Events
B. Profit Margin
C. Toxicity
D. None Of The Above
The Post-Marketing Phase Monitors Adverse Events To Ensure Continued Safety In The
General Population.
